Literature DB >> 4582620

Expression of cell surface markers on T and B lymphocytes after long-term chemotherapy of acute leukemia.

L Sen, L Borella.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4582620     DOI: 10.1016/0008-8749(73)90170-6

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


× No keyword cloud information.
  8 in total

1.  Letter: Measles encephalitis during immunosuppressive treatment.

Authors:  M Reid; A W Craft
Journal:  Br Med J       Date:  1976-07-31

2.  Immune status of children with and without severe infection during remission of malignant disease.

Authors:  J Graham-Pole; M L Willoughby; S Aitken; A Ferguson
Journal:  Br Med J       Date:  1975-05-31

3.  Serial studies of numbers of circulating T and B lymphocytes in children with acute lymphoblastic leukaemia.

Authors:  M M Reid; A W Craft; J A Todd
Journal:  Arch Dis Child       Date:  1977-03       Impact factor: 3.791

4.  Function of surface-adherent cells in the induction of the human mixed leucocyte reaction. I. The transient surface adherence of responding lymphocytes in the human mixed leucocyte response.

Authors:  A Demus; W S Walker; L Borella
Journal:  Clin Exp Immunol       Date:  1974-11       Impact factor: 4.330

5.  Serial studies of immunocompetence of patients undergoing chemotherapy for acute leukemia.

Authors:  E M Hersh; J U Gutterman; G M Mavligit; K B McCredie; M A Burgess; A Matthews; E J Freireich
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

6.  Influence of different cytotoxic drugs on T and B lymphocytes in children with all during remission maintenance therapy.

Authors:  J Ritter; J Oehme
Journal:  Eur J Pediatr       Date:  1976-12-09       Impact factor: 3.183

7.  Pre-B and B cells in children on leukaemia remission maintenance treatment.

Authors:  P Paolucci; A R Hayward; N T Rapson
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

8.  Recovery of immune function after cessation of maintenance therapy in acute lymphoblastic leukemia (ALL) of childhood.

Authors:  G A de Vaan; P J van Munster; J A Bakkeren
Journal:  Eur J Pediatr       Date:  1982-10       Impact factor: 3.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.